Literature DB >> 17371901

Fatigue and activity dependent changes in axonal excitability in amyotrophic lateral sclerosis.

Steve Vucic1, Arun V Krishnan, Matthew C Kiernan.   

Abstract

BACKGROUND: While patients with amyotrophic lateral sclerosis (ALS) may complain of fatigue, the underlying mechanisms appear complex, with dysfunction of central and peripheral nervous systems independently reported as contributing factors. The aim of the present study was to further delineate the mechanisms underlying increased fatigability in ALS by measuring activity dependent changes in axonal excitability following a maximum voluntary contraction (MVC).
METHODS: Nerve excitability changes were recorded before and after an MVC of the abductor pollicis brevis in 16 patients with ALS and 25 controls.
RESULTS: In patients with ALS, there was a greater increase in threshold (36.5 (5.9)%; controls 19.6 (3.5)%; p<0.05) as a result of MVC, with reduction in the amplitude of the compound muscle action potential generated by a submaximal stimulus (ALS 49 (7.6)%; controls 41.0 (5.4)%). These changes were associated with an increase in superexcitability (ALS 65.1 (25.4)%; controls 42.3 (5.7)%) and reduction in strength-duration time constant (ALS 20 (4.9)%; controls 10 (2.5)%; p<0.01), indicative of axonal hyperpolarisation. The increase in threshold was more pronounced in patients with ALS with predominantly lower motor neuronal involvement.
CONCLUSIONS: Higher firing rates of surviving motor axons attempting to compensate for neurogenic weakness are likely to explain the greater activity dependent changes in ALS. As such, the present study suggests a further peripheral factor underlying the development of fatigue in ALS.

Entities:  

Mesh:

Year:  2007        PMID: 17371901      PMCID: PMC2117598          DOI: 10.1136/jnnp.2006.112078

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  49 in total

1.  SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter

Authors: 
Journal:  Nat Neurosci       Date:  1999-09       Impact factor: 24.884

2.  Motor neurone disease: a Pandora's box.

Authors:  Matthew C Kiernan
Journal:  Med J Aust       Date:  2003-04-07       Impact factor: 7.738

3.  Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite.

Authors:  J P Crow; J B Sampson; Y Zhuang; J A Thompson; J S Beckman
Journal:  J Neurochem       Date:  1997-11       Impact factor: 5.372

4.  Assessment of cortical excitability using threshold tracking techniques.

Authors:  Steve Vucic; James Howells; Louise Trevillion; Matthew C Kiernan
Journal:  Muscle Nerve       Date:  2006-04       Impact factor: 3.217

Review 5.  Threshold tracking techniques in the study of human peripheral nerve.

Authors:  H Bostock; K Cikurel; D Burke
Journal:  Muscle Nerve       Date:  1998-02       Impact factor: 3.217

6.  Quantitative assessment of motor fatigue in amyotrophic lateral sclerosis.

Authors:  M Sanjak; J Brinkmann; D S Belden; K Roelke; A Waclawik; H E Neville; S P Ringel; J R Murphy; B R Brooks
Journal:  J Neurol Sci       Date:  2001-10-15       Impact factor: 3.181

7.  Motor drive and metabolic responses during repeated submaximal contractions in humans.

Authors:  N K Vøllestad; O M Sejersted; R Bahr; J J Woods; B Bigland-Ritchie
Journal:  J Appl Physiol (1985)       Date:  1988-04

8.  Ischemic resistance of cutaneous afferents and motor axons in patients with amyotrophic lateral sclerosis.

Authors:  I Mogyoros; M C Kiernan; D Burke; H Bostock
Journal:  Muscle Nerve       Date:  1998-12       Impact factor: 3.217

9.  Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity.

Authors:  J D Rothstein; L Jin; M Dykes-Hoberg; R W Kuncl
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

10.  Stoichiometry and voltage dependence of the sodium pump in voltage-clamped, internally dialyzed squid giant axon.

Authors:  R F Rakowski; D C Gadsby; P De Weer
Journal:  J Gen Physiol       Date:  1989-05       Impact factor: 4.086

View more
  14 in total

1.  Amyotrophic lateral sclerosis and the neuroprotective potential of exercise.

Authors:  Matthew C Kiernan
Journal:  J Physiol       Date:  2009-08-01       Impact factor: 5.182

2.  Transposed firing activation of motor units.

Authors:  Carlo J De Luca; Joshua C Kline; Paola Contessa
Journal:  J Neurophysiol       Date:  2014-06-03       Impact factor: 2.714

Review 3.  Axonal Excitability in Amyotrophic Lateral Sclerosis : Axonal Excitability in ALS.

Authors:  Susanna B Park; Matthew C Kiernan; Steve Vucic
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

4.  Is IVIg therapy warranted in progressive lower motor neuron syndromes without conduction block?

Authors:  Neil G Simon; Gretchen Ayer; Catherine Lomen-Hoerth
Journal:  Neurology       Date:  2013-11-08       Impact factor: 9.910

5.  Transynaptic changes evident in peripheral axonal function after acute cerebellar infarct.

Authors:  William Huynh; Cindy S-Y Lin; Arun V Krishnan; Steve Vucic; Matthew C Kiernan
Journal:  Cerebellum       Date:  2014-12       Impact factor: 3.847

6.  Excitability and the safety margin in human axons during hyperthermia.

Authors:  James Howells; Dirk Czesnik; Louise Trevillion; David Burke
Journal:  J Physiol       Date:  2013-04-22       Impact factor: 5.182

7.  Effect of fluoxetine on disease progression in a mouse model of ALS.

Authors:  J E Koschnitzky; K A Quinlan; T J Lukas; E Kajtaz; E J Kocevar; W F Mayers; T Siddique; C J Heckman
Journal:  J Neurophysiol       Date:  2014-03-05       Impact factor: 2.714

Review 8.  Controversies and priorities in amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Orla Hardiman; Michael Benatar; Benjamin R Brooks; Adriano Chio; Mamede de Carvalho; Paul G Ince; Cindy Lin; Robert G Miller; Hiroshi Mitsumoto; Garth Nicholson; John Ravits; Pamela J Shaw; Michael Swash; Kevin Talbot; Bryan J Traynor; Leonard H Van den Berg; Jan H Veldink; Steve Vucic; Matthew C Kiernan
Journal:  Lancet Neurol       Date:  2013-03       Impact factor: 44.182

9.  The puzzling case of hyperexcitability in amyotrophic lateral sclerosis.

Authors:  Jong Seok Bae; Neil G Simon; Parvathi Menon; Steve Vucic; Matthew C Kiernan
Journal:  J Clin Neurol       Date:  2013-04-04       Impact factor: 3.077

10.  Dissecting the mechanisms underlying short-interval intracortical inhibition using exercise.

Authors:  Steve Vucic; Benjamin C Cheah; Matthew C Kiernan
Journal:  Cereb Cortex       Date:  2010-11-11       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.